MANNATECH INC (MTEX) Stock Fundamental Analysis

NASDAQ:MTEX • US5637712036

7.222 USD
+0.01 (+0.17%)
Last: Feb 13, 2026, 08:27 PM
Fundamental Rating

2

Overall MTEX gets a fundamental rating of 2 out of 10. We evaluated MTEX against 36 industry peers in the Personal Care Products industry. MTEX may be in some trouble as it scores bad on both profitability and health. MTEX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • MTEX had negative earnings in the past year.
  • MTEX had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: MTEX reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: MTEX reported negative operating cash flow in multiple years.
MTEX Yearly Net Income VS EBIT VS OCF VS FCFMTEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

1.2 Ratios

  • The Return On Assets of MTEX (-4.88%) is worse than 66.67% of its industry peers.
  • MTEX has a Return On Equity of -23.83%. This is in the lower half of the industry: MTEX underperforms 66.67% of its industry peers.
  • The Return On Invested Capital of MTEX (2.75%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.88%
ROE -23.83%
ROIC 2.75%
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
MTEX Yearly ROA, ROE, ROICMTEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • MTEX's Profit Margin has been stable in the last couple of years.
  • MTEX has a Operating Margin of 0.54%. This is comparable to the rest of the industry: MTEX outperforms 44.44% of its industry peers.
  • MTEX's Operating Margin has declined in the last couple of years.
  • MTEX has a Gross Margin of 76.33%. This is amongst the best in the industry. MTEX outperforms 83.33% of its industry peers.
  • In the last couple of years the Gross Margin of MTEX has remained more or less at the same level.
Industry RankSector Rank
OM 0.54%
PM (TTM) N/A
GM 76.33%
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
MTEX Yearly Profit, Operating, Gross MarginsMTEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MTEX is destroying value.
  • MTEX has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MTEX has less shares outstanding
  • The debt/assets ratio for MTEX is higher compared to a year ago.
MTEX Yearly Shares OutstandingMTEX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
MTEX Yearly Total Debt VS Total AssetsMTEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • MTEX has an Altman-Z score of 3.60. This indicates that MTEX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of MTEX (3.60) is better than 72.22% of its industry peers.
  • MTEX has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
  • MTEX has a Debt to Equity ratio of 0.48. This is comparable to the rest of the industry: MTEX outperforms 52.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 3.6
ROIC/WACC0.3
WACC9.22%
MTEX Yearly LT Debt VS Equity VS FCFMTEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 1.13 indicates that MTEX should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.13, MTEX is doing worse than 72.22% of the companies in the same industry.
  • MTEX has a Quick Ratio of 1.13. This is a bad value and indicates that MTEX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MTEX's Quick ratio of 0.56 is on the low side compared to the rest of the industry. MTEX is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.56
MTEX Yearly Current Assets VS Current LiabilitesMTEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

0

3. Growth

3.1 Past

  • The earnings per share for MTEX have decreased by -5.28% in the last year.
  • MTEX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.73% yearly.
  • MTEX shows a decrease in Revenue. In the last year, the revenue decreased by -9.17%.
  • Measured over the past years, MTEX shows a decrease in Revenue. The Revenue has been decreasing by -5.66% on average per year.
EPS 1Y (TTM)-5.28%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%695.35%
Revenue 1Y (TTM)-9.17%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-8.08%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MTEX Yearly Revenue VS EstimatesMTEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

4. Valuation

4.1 Price/Earnings Ratio

  • MTEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MTEX Price Earnings VS Forward Price EarningsMTEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MTEX is valued cheaper than 86.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.7
MTEX Per share dataMTEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 8.83%, MTEX is a good candidate for dividend investing.
  • In the last 3 months the price of MTEX has falen by -24.69%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • MTEX's Dividend Yield is rather good when compared to the industry average which is at 1.61. MTEX pays more dividend than 94.44% of the companies in the same industry.
  • MTEX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.79.
Industry RankSector Rank
Dividend Yield 8.83%

5.2 History

  • MTEX has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MTEX Yearly Dividends per shareMTEX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
MTEX Yearly Income VS Free CF VS DividendMTEX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

MANNATECH INC

NASDAQ:MTEX (2/13/2026, 8:27:13 PM)

7.222

+0.01 (+0.17%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-11
Earnings (Next)03-24
Inst Owners19.24%
Inst Owner Change-3.71%
Ins Owners44.9%
Ins Owner Change2.85%
Market Cap13.72M
Revenue(TTM)110.41M
Net Income(TTM)-1.66M
Analysts0
Price TargetN/A
Short Float %2.09%
Short Ratio0.84
Dividend
Industry RankSector Rank
Dividend Yield 8.83%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 1.97
P/tB 1.97
EV/EBITDA 5.7
EPS(TTM)-0.86
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.09
FCFYN/A
OCF(TTM)-1.52
OCFYN/A
SpS58.11
BVpS3.66
TBVpS3.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.88%
ROE -23.83%
ROCE 4.13%
ROIC 2.75%
ROICexc 5.44%
ROICexgc 5.44%
OM 0.54%
PM (TTM) N/A
GM 76.33%
FCFM N/A
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-38.98%
ROICexgc growth 5Y-10.83%
ROICexc growth 3Y-39.31%
ROICexc growth 5Y-11.41%
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
F-Score3
Asset Turnover3.26
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA 1.88
Cap/Depr 89.97%
Cap/Sales 0.97%
Interest Coverage 1.1
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.56
Altman-Z 3.6
F-Score3
WACC9.22%
ROIC/WACC0.3
Cap/Depr(3y)43.45%
Cap/Depr(5y)43.17%
Cap/Sales(3y)0.53%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.28%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%695.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.17%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-8.08%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y283.08%
EBIT growth 3Y-45.85%
EBIT growth 5Y-25.91%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y17.66%
FCF growth 3Y-42.1%
FCF growth 5Y-11.9%
OCF growth 1Y29.61%
OCF growth 3Y-40.57%
OCF growth 5Y-14.4%

MANNATECH INC / MTEX FAQ

Can you provide the ChartMill fundamental rating for MANNATECH INC?

ChartMill assigns a fundamental rating of 2 / 10 to MTEX.


What is the valuation status for MTEX stock?

ChartMill assigns a valuation rating of 1 / 10 to MANNATECH INC (MTEX). This can be considered as Overvalued.


Can you provide the profitability details for MANNATECH INC?

MANNATECH INC (MTEX) has a profitability rating of 2 / 10.


Is the dividend of MANNATECH INC sustainable?

The dividend rating of MANNATECH INC (MTEX) is 5 / 10 and the dividend payout ratio is 0%.